
Lupin Limited has informed the Exchange regarding a press release dated July 26, 2023, titled "Lupin Receives Approval from TGA Australia for Tiotropium Dry Powder forInhaler for Treatment of COPD.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated July 26, 2023, titled "Lupin Receives Approval from TGA Australia for Tiotropium Dry Powder forInhaler for Treatment of COPD.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin